🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Caregiver Burden in Parkinson's Disease

Recruitingn/aAges 40 Years - 80 YearsAllBeylikduzu State Hospital
NCT06892717 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Primary caregivers of patients diagnosed with idiopathic Parkinson's disease will be included in the study. A total of 43 participants will be recruited. At the beginning of the study, demographic data and clinical characteristics of the patients, including disease stage, history of falls, presence of fractures, presence and severity of pain, comorbidities, and medication use, will be recorded. Subsequently, caregivers' age, gender, occupation, relationship to the patient, caregiving duration, and their own comorbidities will be assessed. Sleep problems will be evaluated using the Insomnia Severity Index (ISI), while symptoms related to depression and anxiety will be assessed with the Hospital Anxiety and Depression Scale (HADS). Caregiver burden will be examined using the Zarit Caregiver Burden Scale.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 40-80 years * Diagnosed with Parkinson's disease, Hoehn and Yahr stage 2-5 * Requires assistance in daily activities * Informal caregiver providing care (unpaid, typically a family member such as a spouse or child) * Caregiver has sufficient proficiency in Turkish to understand and respond to the study questions Exclusion Criteria: * Presence of any additional neurodegenerative disease other than Parkinson's disease * Diagnosis of Chronic Obstructive Pulmonary Disease (COPD) * Advanced heart failure classified as New York Heart Association (NYHA) Class IV (symptoms at rest) * Active cancer disease * History of stroke causing limitations in daily life * Immobility due to reasons other than Parkinson's disease
💊

What it tests

📍

Where

1 site
Beylikdüzü State Hospital
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy